Harvard Bioscience stock holds at USD 7.92 after reverse split

Published on 09/23/2026 at 12:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Harvard Bioscience stock traded at USD 7.92 on September 23, 2026, with a USD 36.054 million market value. Robinhood records a 1 for 10 reverse split.

HBIO, US4169061052, Illustration mit AI erstellt.

Harvard Bioscience, Inc. (US4169061052) traded at USD 7.92 on Nasdaq on September 23, 2026, while its market capitalization stood at USD 36.054 million. The quoted market data also showed a daily change of minus 1.00 percent.

Reverse split changes the reference base

Robinhood records a 1 for 10 reverse split for Harvard Bioscience on September 23, 2026. The action means that shareholders received 1 share for every 10 shares previously held, so historical price comparisons require split-adjusted data.

The split is the clearest company-specific event in the current trading snapshot. With a market value of USD 36.054 million on September 23, 2026, the stock remains a small-cap medical-instruments name, and the post-split quote provides the more useful reference for current market positioning.

Market value defines the focus

The Nasdaq quote of USD 7.92 on September 23, 2026, was accompanied by a 1.00 percent decline for the session. That combination places the stock's immediate story in market capitalization and corporate-action mechanics rather than in a newly substantiated earnings figure.

The reverse split also makes the date important: a USD 7.92 quote after the 1 for 10 action cannot be compared directly with an earlier unadjusted quotation. For investors assessing Harvard Bioscience, the split ratio and the USD 36.054 million market value are therefore the two central numerical reference points from September 23, 2026.

Stock trades at USD 7.92

Harvard Bioscience stock traded at USD 7.92 on Nasdaq as of September 23, 2026, down 1.00 percent on the session. The market capitalization was USD 36.054 million on the same date.